DaVita Inc. logo

DaVita Inc. (DVA)

Market Closed
22 Jul, 20:00
NYSE NYSE
$
232. 08
-5.2
-2.1915%
$
15.21B Market Cap
16.41 P/E Ratio
- Div Yield
979,361 Volume
7.83 Eps
$ 237.28
Previous Close
Add Transaction
Day Range
230.35 237.11
Year Range
101 239.64
Want to track DVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Should Value Investors Buy DaVita (DVA) Stock?

Should Value Investors Buy DaVita (DVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Here is how DaVita HealthCare (DVA) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.

Zacks | 1 year ago
DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?

DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?

DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.

Zacks | 1 year ago
Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice

Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 year ago
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
3 Stocks Warren Buffett Owns More Than 10% of Right Now

3 Stocks Warren Buffett Owns More Than 10% of Right Now

In August, Warren Buffett's Berkshire Hathaway (NYSE: BRK-B) became the first non-tech U.S.

247wallst | 1 year ago
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market

Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market

DaVita HealthCare (DVA) closed the most recent trading day at $163.16, moving -0.65% from the previous trading session.

Zacks | 1 year ago
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know

DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know

In the most recent trading session, DaVita HealthCare (DVA) closed at $164.22, indicating a -0.59% shift from the previous trading day.

Zacks | 1 year ago
3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN

3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN

Stocks making new highs tend to make even higher highs, particularly when positive earnings estimate revisions hit the tape. And that's precisely what these three companies have seen.

Zacks | 1 year ago
DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out?

DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out?

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 year ago
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock

Here's Why DaVita HealthCare (DVA) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Are Investors Undervaluing DaVita (DVA) Right Now?

Are Investors Undervaluing DaVita (DVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Loading...
Load More